A novel way to improve survival and recovery rate after a heart attack was reported in the journal Stem Cell Research. This method, developed in laboratory research with pigs, is the first noncell based therapeutic application of human embryonic stem cells. It entails using secretions from stem cells.
Eurek Alert
Full Story